Chemiluminescence is the process of converting chemical energy into visible light that is emitted as the result of chemical (oxidation or hydrolysis) reaction. This process offers sensitive and cost-effective detection methods to several radio-isotopic and fluorescence techniques and most chromogenic detection processes. Chemiluminescence imaging is the process of capturing the series of images during identification of low abundance proteins. Chemiluminescent imaging enables accurate quantification of Western blots with a real-time display.
Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2497
Global Chemiluminescence Imaging Market: Regional Analysis
On the basis of region, the global chemiluminescence imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global chemiluminescence imaging market. This is owing to increasing research studies for forensic human identification by using methods such as DNA profiling, forensic anthropology, forensic radiography, and forensic odontology in which chemiluminescence imaging plays crucial role for identification and detection of proteomics and genomics.
Furthermore, Europe is expected to witness significant growth in the global chemiluminescence imaging market, owing to launch of new products in the region. For Instance, in 2017, Syngene, a manufacturer of image analysis solutions, launched its new GeneGnome XRQ — a dedicated chemiluminescence imaging system. The new GeneGnome XRQ is designed to rapidly and accurately image chemiluminescent Western blots. It consists of high-quality F/0.95 fixed focus, cooled camera with on chip integration and GeneSys software.
Key players operating in the global chemiluminescence imaging market include, LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co. KG, Bio-Rad Laboratories, Inc., Cleaver Scientific Ltd, Next Advance, Inc., Syngene, GE Healthcare, Vilber Smart Imaging, Inc., Thermo Fisher Scientific, Analytik Jena Life Science, PerkinElmer, Inc., and ANALIS sa/nv.